Close menu




July 1st, 2026 | 07:30 CEST

Worry-Free Dividends: Best Buy and Unilever Are Turning the Corner—RE Royalties Offers Deep Value and a 10% Dividend

  • royalties
  • dividends
  • Investments
  • renewableenergy
Photo credits: AI

War or peace? Rarely has the global situation been so chaotic. Even the AI hype, which has driven stock prices higher for years, is fading. So what should investors do? Stable income generators, such as solid dividend stocks, have always been in demand during comparable market phases. But which dividend stock is truly a good choice? While many large corporations are having to reinvent themselves, innovative players in promising niches are shaking up entire markets. A comparison of the three companies—Best Buy, Unilever, and RE Royalties—shows what matters most to dividend investors right now.

time to read: 3 minutes | Author: Nico Popp
ISIN: RE ROYALTIES LTD | CA75527Q1081 | TSXV: RE , OTCQX: RROYF , UNILEVER PLC LS-_031111 | GB00B10RZP78 , BEST BUY CO. DL-_10 | US0865161014

Table of contents:


    Best Buy: A Turnaround Thanks to Multiple Revenue Streams

    US electronics retailer Best Buy is overcoming the weak margins of traditional retail by expanding its digital platforms. In the 2026 fiscal year, the company reported total revenue of USD 41.691 billion and achieved positive like-for-like revenue growth of 0.5% for the first time in four years. This upward trend accelerated in the first quarter of the current fiscal year, with revenue rising 1.9% to USD 8.936 billion—significantly exceeding market expectations. Management leverages the "Best Buy Marketplace" digital marketplace and the in-house retail media network "Best Buy Ads" as supplementary revenue streams, generating advertising and fee revenue through these channels. Thanks to the turnaround, management is pursuing a shareholder-friendly policy. Following distributions and buybacks totaling USD 1.07 billion in the 2026 fiscal year, Best Buy raised its quarterly dividend by about 1% to USD 0.96 per share. Best Buy has thus increased its dividend for 12 consecutive years.

    Unilever: Corporate Restructuring for Greater Profitability

    Consumer goods giant Unilever is overhauling its global portfolio to divest itself of capital-intensive and seasonally vulnerable divisions. Underlying revenue growth was impressive in fiscal year 2025, rising by 3.5%, although nominal revenue fell by 3.8% to EUR 50.5 billion due to negative currency effects and divestitures. The profitable "Power Brands," which account for approximately 78% of consolidated revenue, grew at a disproportionately high rate. To become even more profitable, Unilever is focusing on divestitures and spin-offs. In December 2025, the ice cream business was spun off as part of a demerger under the name "The Magnum Ice Cream Company". Further measures were taken in the first quarter of 2026, including the sale of the home care business in Colombia and Ecuador, the Graze snack brand, and the Indonesian tea business. Following the planned spin-off of the Foods segment, Unilever will remain a pure "Home & Personal Care provider." Shareholders currently receive a stable quarterly dividend of approximately EUR 0.47 per share and benefit from a EUR 1.5 billion share buyback program.

    RE Royalties: The Innovative Royalty Model for the Global Energy Transition

    Vancouver-based RE Royalties has successfully adapted the proven asset-light royalty model from the commodities sector to the renewable energy sector. The company is a specialized financier and occupies a critical niche in financings ranging from CAD 10 to 30 million, a segment often overlooked by traditional banks. In exchange for secured loans, RE Royalties secures long-term, contractually fixed gross revenue shares over terms of up to 25 years. This royalty model protects RE Royalties from project risks and guarantees long-term revenue streams.

    RE Royalties: Exciting business model, promising stock.

    To raise capital for investments, RE Royalties can rely on so-called green bonds, which are in demand on the market and offer attractive terms for all parties involved. In addition to solar and wind power plants, RE Royalties is also focusing on battery storage, thereby diversifying its portfolio. Since the company is already active in many countries, it possesses extensive expertise and is regarded as a sought-after partner by both investors and project operators. Nevertheless, management has identified further potential and, as early as March of this year, initiated a comprehensive strategic review process conducted by PricewaterhouseCoopers. The advisors are tasked with examining all options, including a recapitalization, strategic partnerships, or a complete sale—the goal is to enhance value for shareholders. The market is using Altius Minerals' acquisition of Lithium Royalty, announced in 2025 and valued at CAD 520 million, as a valuation blueprint.

    Conclusion: Promising Outlook for RE Royalties

    The transaction demonstrates that royalties are sought-after investments and that the associated long-term income streams are not always adequately valued on the open market—only the buyer, Altius Minerals, recognized the potential and was willing to pay a hefty premium. The management of RE Royalties hopes that the review by PricewaterhouseCoopers will provide a similar breakthrough. At a time when renewable energy is in high demand worldwide, and institutional investors are once again prioritizing inflation-protected investments, RE Royalties could be poised for a revaluation. The stock has been stable for several months and is trending slightly upward. Given an attractive dividend yield of around 10%, investors can also more easily weather minor fluctuations in the stock price. This dividend stock with growth potential is a must-add to your watchlist.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by Armin Schulz on July 1st, 2026 | 06:55 CEST

    Cameco, American Atomics, and Centrus Energy: How to Capitalize on the Revaluation of the Entire Sector

    • nuclear
    • Uranium
    • Energy
    • renewableenergy
    • decarbonization

    The uranium market is currently undergoing not just another commodity boom, but a strategic realignment across the entire value chain. Security of supply and industrial sovereignty have long since elevated nuclear fuel to a matter of national security. For investors, the focus is shifting from the mere spot price to critical bottlenecks in processing and enrichment. The actual value creation no longer occurs solely in the ground, but rather where ore is transformed into usable fuel. Whoever controls these key nodes secures the margins. Cameco, American Atomics, and Centrus Energy demonstrate how stability, leverage, and strategic scarcity can be profitably combined within the same market environment.

    Read

    Commented by Fabian Lorenz on June 30th, 2026 | 07:20 CEST

    The US Is Pumping Billions into the Market! Uranium Stocks Like Cameco and American Atomics Are Back! What About Plug Power?

    • nuclear
    • Uranium
    • Hydrogen
    • Energy
    • renewableenergy

    Uranium stocks are poised for a comeback. The US government is providing billions to build nuclear power plants faster and more affordably. The spot price for uranium is still low; however, one expert sees momentum and forecasts a significant price increase. Cameco should benefit from this as a core investment. American Atomics could be poised for outperformance. The Canadian explorer is working on an integrated uranium value chain in North America. Its projects in the US states of Utah and Colorado are promising. And what about Plug Power? The stock lost over 35% of its value in June. Can the latest news halt the downward trend? Analysts see upside potential.

    Read

    Commented by André Will-Laudien on June 29th, 2026 | 07:30 CEST

    AI and M&A Frenzy in the Life Sciences Sector: Bayer, Vidac Pharma, Novo Nordisk, Evotec, and Eli Lilly

    • Biotechnology
    • Pharma
    • Biotech
    • AI
    • Investments

    Yes, you read that correctly. Pharmaceutical companies are actively embracing artificial intelligence (AI) and, thanks to lower costs, better validation, and faster study setups, could emerge as winners of the new AI wave in the medium term. Many stocks in the life sciences sector had been overlooked by the market, but investors are now taking notice again. Eli Lilly is betting on AI and expanding its portfolio through targeted acquisitions, including the takeovers of sleep-wake specialist Centessa Pharmaceuticals and blood cancer specialist Ajax. At Evotec and Vidac Pharma, much of the focus is on cancer, while Novo Nordisk faces stiff competition from Eli Lilly's weight-loss drugs. Then came the welcome news regarding Bayer. The Supreme Court ruled that approximately 181,000 individual lawsuits alleging a lack of warning labels on packaging are no longer legally viable, as the US Environmental Protection Agency (EPA) has classified the herbicide glyphosate as safe. Lots of good news, and plenty of opportunities for active investors - we provide a few insights.

    Read